BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10470122)

  • 1. G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines.
    Bache M; Dunst J; Würl P; Fröde D; Meye A; Schmidt H; Rath FW; Taubert H
    Anticancer Res; 1999; 19(3A):1827-32. PubMed ID: 10470122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
    Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control.
    Strunz AM; Peschke P; Waldeck W; Ehemann V; Kissel M; Debus J
    Int J Radiat Biol; 2002 Aug; 78(8):721-32. PubMed ID: 12194756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint.
    Stuschke M; Sak A; Wurm R; Sinn B; Wolf G; Stüben G; Budach V
    Int J Radiat Biol; 2002 Sep; 78(9):807-19. PubMed ID: 12428922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
    Badie C; Bourhis J; Sobczak-Thépot J; Haddada H; Chiron M; Janicot M; Janot F; Tursz T; Vassal G
    Br J Cancer; 2000 Feb; 82(3):642-50. PubMed ID: 10682678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation.
    Ning S; Knox SJ
    Radiat Res; 1999 Jun; 151(6):659-69. PubMed ID: 10360785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.
    Zhao H; Spitz MR; Tomlinson GE; Zhang H; Minna JD; Wu X
    Cancer Res; 2001 Nov; 61(21):7819-24. PubMed ID: 11691798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
    Kappler M; Bache M; Bartel F; Kotzsch M; Panian M; Würl P; Blümke K; Schmidt H; Meye A; Taubert H
    Cancer Gene Ther; 2004 Mar; 11(3):186-93. PubMed ID: 14739938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair.
    Schwartz D; Almog N; Peled A; Goldfinger N; Rotter V
    Oncogene; 1997 Nov; 15(21):2597-607. PubMed ID: 9399647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line.
    Kappler M; Taubert H; Bartel F; Blümke K; Panian M; Schmidt H; Dunst J; Bache M
    Oncol Rep; 2005 Jan; 13(1):167-72. PubMed ID: 15583820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation.
    Merritt AJ; Allen TD; Potten CS; Hickman JA
    Oncogene; 1997 Jun; 14(23):2759-66. PubMed ID: 9190891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
    Scott SL; Earle JD; Gumerlock PH
    Cancer Res; 2003 Nov; 63(21):7190-6. PubMed ID: 14612513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
    Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
    Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.
    Warenius HM; Jones M; Gorman T; McLeish R; Seabra L; Barraclough R; Rudland P
    Br J Cancer; 2000 Oct; 83(8):1084-95. PubMed ID: 10993658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tumor suppressor p53 facilitates DNA repair but not UV-induced G2/M arrest or apoptosis in Chinese hamster ovary CHO-K1 cells.
    Chang YC; Liao CB; Hsieh PY; Liou ML; Liu YC
    J Cell Biochem; 2008 Feb; 103(2):528-37. PubMed ID: 17549699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.
    Guillouf C; Rosselli F; Krishnaraju K; Moustacchi E; Hoffman B; Liebermann DA
    Oncogene; 1995 Jun; 10(11):2263-70. PubMed ID: 7784074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of apoptosis-resistant mutants from a radiosensitive mouse lymphoma cell line.
    Kawai H; Kitamura Y; Nikaido O; Tatsuka M; Hama-Inaba H; Muto M; Ohyama H; Suzuki F
    Radiat Res; 1998 Jan; 149(1):41-51. PubMed ID: 9421153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
    McIlwrath AJ; Vasey PA; Ross GM; Brown R
    Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.